Cheapest Compounded Tirzepatide (October 2026): 23 Providers Ranked by Price

How we built this list: We recorded the lowest compounded tirzepatide price each provider publishes on its own website between October 3 and October 7, 2026. Where a provider doesn’t publish the plan terms clearly, we used a dated third-party report and marked it. We didn’t enroll or buy anything. Every provider’s source page is listed in our price tracker. For why tirzepatide costs what it does, see our compounded tirzepatide cost guide. The semaglutide version of this list is here.

The short answer

• Lowest headline price: Embody at $119/mo. Its homepage calls it a flat rate for “GLP-1 / GIP injections” but doesn’t say what plan length it requires.
• Lowest price with published plan terms: Trimi at $125/mo, but only on a 12-month plan billed $1,500 upfront. Its month-to-month price is $235.
• Lowest with no long commitment (and no FDA warning letter): Mochi Health from $169/mo, a $79 membership plus medication from $90 that can rise with your dose.
• Lowest among our Featured providers: Gala at $199/mo on a 3-month plan. Fridays lists $240/mo prepaid annually, and showed a $198/mo promo on October 7.

As with semaglutide, the cheapest monthly figure is rarely the cheapest way to start. A $125 plan billed $1,500 upfront puts far more money at risk on day one than one month at $235.

Every published price, lowest first

Prices are per month for compounded tirzepatide, as advertised. “No-commitment price” is the month-to-month price where the provider publishes one. Scores and labels come from our rankings and methodology; price isn’t the only thing they measure.

Provider	Lowest advertised	Plan you have to buy	No-commitment price	Our score	FDA warning letter?	Checked
Embody	$119	Homepage flat rate; plan length not stated	Not published	7.5 Caution	None found	Oct 7
Trimi	$125	12 months, $1,500 upfront	$235	8.1 Caution	None found	Oct 7
NexLife	$139	12-month plan	$169	6.6 Caution	Yes, Jun 8, 2026	Oct 7
CoreAge Rx	$149	12 months, $1,788 upfront*	Not published	6.6 Caution	None found	Oct 7
Sprout Health	$149	12 months, $1,788 upfront	$199 per 4 weeks	6.4 Caution	Yes, Sep 9, 2025	Oct 7
altRx	$149	Monthly enrollment promo	$149 promo	6.5 Caution	Yes, Jun 8, 2026	Oct 3
TMates	$167	12-month plan	Not published	5.7 High caution	None found	Oct 7
Mochi Health	$169	$79 membership + medication from $90	$169	6.6 Caution	None found	Oct 7
HealthRX	$179	12 months, $2,148 upfront	$239 (renews at $214)	6.9 Caution	None found	Oct 7
bmiMD	$179	“As low as” (list $299.70)	Not published	7.7 Caution	None found	Oct 7
Gala	$199	3-month plan (“start for $179” also shown)	Not published	8.2 Featured	None found	Oct 7
Ivim	$208	6 months ($133 medication + $75 membership)	Not published	6.2 Caution	Yes, Feb 20, 2026	Oct 7
Yucca Health	$225	6 months, $1,350 total	$258 (Oct 2)	7.9 Caution	None found	Oct 7
Found	$239	12-month cash plan, per 28-day cycle	$359 ($219 first month)	8.3 Featured	None found	Oct 7
Fridays	$240	12 months, prepaid	$359	8.5 Featured	None found	Oct 7
Elevate Health	$248	12-month plan	$399–$449	6.4 Caution	None found	Oct 3*
Maximus	$249.99	2-month plan	Not published	5.9 High caution	Yes, Jun 8, 2026	Oct 7
TrimRx	$259	Starting price	Not published	6.5 Caution	None found	Oct 2
Enhance MD	$280	All doses ($180 first month)	$280	8.6 Featured	None found	Oct 7
OrderlyMeds	$299	Monthly ($149 first month)	$299	6.2 Caution	Yes, Jun 8, 2026	Oct 7
HumeCare+	$299	Monthly, plus a consultation fee each refill	$299 + fee	6.3 Caution	None found	Oct 3*
Aspen	$299	12-month prepay	$399	7.8 Caution	None found	Oct 3*
Wellorithm	$349	Per 28-day cycle ($249 first order)	$349	6.5 Caution	None found	Oct 3*

* Plan terms or price taken from a dated third-party report because the provider doesn’t publish them clearly; see the price tracker for the exact source. All checks were in 2026.

Compounded tirzepatide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality. The prices above are advertised prices, not quotes; your clinician’s prescribed dose and your plan can change what you pay.

Not in the table: Oak Longevity, MEDGm, FeelGood, Direct Meds, Strut Health and the other providers we track don’t publish a compounded tirzepatide price on their own pages before intake. Third-party sites report Oak at roughly $185–$199/mo, but we couldn’t find that figure on Oak’s own pages; see our Oak Longevity review.

What a year actually costs

Monthly figures hide how much you pay up front. Here’s the first-year cost at the lowest published plan for the providers whose terms are clear:

Provider	Plan	Paid at checkout	First-year total
Trimi	Annual	$1,500	$1,500
Sprout Health	12-month	$1,788	$1,788
HealthRX	12-month	$2,148	$2,148
Gala	3-month at $199	$597	$2,388
Fridays	Annual at $240 ($198 promo)	Prepaid annual plan	$2,880 ($2,376 at the promo price)
Trimi	Month-to-month	$235	$2,820
Enhance MD	Monthly, all doses	$180	$3,260
Found	12-month cash, 13 cycles of 28 days	Varies by plan	About $3,107
Fridays	Month-to-month	$359	$4,308

Sprout and Found bill per 4-week (28-day) cycle, which means 13 charges a year rather than 12. Fridays describes its annual plan as “paid annually, delivered monthly”. Confirm the exact checkout charge before you pay.

Cheapest by situation

If you can pay a year upfront

Trimi has the lowest 12-month total we could verify: $1,500. The catch is its refund policy: once a clinician issues your prescription, the order is final. Sprout Health and CoreAge Rx both work out to $1,788, but Sprout received an FDA warning letter in September 2025, and CoreAge’s plan terms come from a third-party report. Our Trimi review walks through the refund rules and pharmacy details.

If you don’t want to commit

Of the providers that publish a month-to-month price and had no FDA warning letter in our checks, Mochi Health ($169), Trimi ($235) and HealthRX ($239, then $214) were the lowest. Mochi’s medication price is “as low as” $90 and rises at higher doses, so its real monthly cost depends on your prescription. Trimi and HealthRX both say their price is the same at every dose.

If you want the lowest price from a Featured provider

Gala is the cheapest of our four Featured providers for tirzepatide at $199/mo on a 3-month plan. Fridays is $240/mo prepaid annually ($359 month-to-month), Found starts at $239 per cycle on a 12-month cash plan, and Enhance MD is $280/mo at every dose. See Fridays vs. Gala and Found vs. Fridays.

If you have insurance

Insurance doesn’t cover compounded tirzepatide itself, but Found has an insurance track: its clinical visits are billed to in-network insurance (typically about a $30 copay per visit, per Found), and its compounded tirzepatide plans on that track start at $179 per cycle on a 12-month plan, plus copays. Found says that track isn’t available to people on Medicare, Medicaid, TRICARE or similar government plans. Details are in our Found vs. Fridays comparison.

Why the cheapest price can cost more

• Prepaid plans. Nearly every price under $180 requires a 6- or 12-month plan. At several providers, payment becomes final once a prescription is issued.
• First-month promos. Enhance MD, OrderlyMeds, Found and Wellorithm show a lower first-month price. Budget for month two.
• Membership plus medication. Mochi and Ivim bill a membership on top of medication. HumeCare+ adds a consultation fee at every refill.
• Dose-based pricing. Tirzepatide is usually prescribed at increasing doses over several months. Flat “every dose” pricing (Trimi, HealthRX, Sprout, NexLife, Found, Enhance MD) protects you from increases; confirm it at checkout.
• Billing cycles. A 28-day cycle means 13 charges a year.

What a low price doesn’t tell you

Six providers in the table received an FDA warning letter between September 2025 and June 2026: NexLife, Sprout Health, altRx, Ivim, Maximus and OrderlyMeds. The letters cover issues such as website claims about compounded semaglutide and tirzepatide that FDA said were false or misleading. You can read each one in the sources below. A warning letter isn’t a ruling that a product is unsafe, but it’s part of our safety record score.

Since FDA removed tirzepatide from its shortage list, the rules for compounding it have tightened. FDA’s April 2026 update says 503A pharmacies may not regularly compound copies of a commercially available drug unless a prescriber documents a significant difference for the individual patient. That can change who offers it and at what price. Our explainer on whether compounded tirzepatide is legal in 2026 covers the details.

Before you choose on price, check three things:

1. Is the pharmacy named? Trimi, Fridays, Enhance MD and NexLife name theirs; many providers don’t. Our guide to 503A vs. 503B pharmacies explains what to look for.
2. Is it labeled not FDA-approved? Providers that blur that line are a red flag.
3. When does your payment become non-refundable? Know this before you prepay.

Bottom line

As of October 7, 2026, the cheapest verifiable compounded tirzepatide is $125/mo on Trimi’s $1,500 annual prepay, or about $169–$239/mo with no long commitment at providers without an FDA warning letter. Among Featured providers, Gala is cheapest at $199/mo on a 3-month plan. Lower headline prices come with caveats: an unstated plan length, a promo, or an FDA warning letter. Whether compounded tirzepatide is appropriate for you is a decision for you and a licensed clinician. Compare every provider in our rankings.